| | | | | | | |
 | JOHNSON & JOHNSON | -0.40% | -1.95% | 0.02% | -1.16% | 30.85% | 449 879 |
| ELI LILLY AND COMPANY | -1.46% | -8.61% | 9.09% | 14.38% | 170.48% | 286 307 |
| PFIZER, INC. | -1.18% | -1.70% | -16.56% | 9.32% | 33.34% | 276 449 |
 | ROCHE HOLDING AG | -0.02% | 0.41% | -16.46% | -10.35% | 20.58% | 271 358 |
| ABBVIE INC. | -0.63% | -7.23% | 1.95% | 20.61% | 113.12% | 244 068 |
 | NOVO NORDISK A/S | -2.96% | -11.48% | 2.86% | 20.59% | 132.87% | 233 797 |
| MERCK & CO., INC. | 0.68% | -2.16% | 14.05% | 15.87% | 3.63% | 221 434 |
 | ASTRAZENECA PLC | 1.36% | 0.43% | 25.21% | 33.21% | 53.56% | 202 796 |
| NOVARTIS AG | 0.85% | 0.42% | 2.20% | -1.74% | -7.48% | 185 657 |
| BRISTOL-MYERS SQUIBB COMPANY | 0.00% | -3.45% | 15.67% | 5.87% | 57.85% | 153 995 |
| AMGEN INC. | -0.30% | -0.49% | 9.46% | 7.00% | 33.50% | 131 727 |
 | SANOFI | 1.22% | 0.31% | 10.08% | 13.06% | 34.98% | 123 992 |
 | BAYER AG | -6.98% | -6.53% | 13.36% | 13.31% | -4.00% | 53 162 |
 | DAIICHI SANKYO CO., LTD. | 1.67% | -1.67% | 18.43% | 74.11% | 52.60% | 49 042 |
| CHUGAI PHARMACEUTICAL CO., LTD | 1.97% | 0.96% | 0.94% | -5.77% | 49.80% | 45 804 |
| | | | | | | |
| | Durchschnitt | -0.41% | -2.85% | 6.02% | 13.89% | 51.71% | |
| | Gewichteter Durchschnitt nach Marktkapitalisierung | -0.44% | -3.21% | 3.38% | 10.47% | 57.60% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Bericht
